Outlook Therapeutics (OTLK.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow

Event Tracking

Dec20

Outlook Therapeutics released FY2025 Annual Earnings on December 19 (EST), actual revenue USD 1.414 M (forecast USD 6.719 M), actual EPS USD -1.794 (forecast USD -1.6425)

04:00

Outlook Therapeutics released FY2025 Q4 earnings on December 19 (EST), actual revenue USD -92.32K (forecast USD 5.846M), actual EPS USD -0.2816 (forecast USD -0.2775)

04:00

Nov14

Douglas Tsao Maintains Hold Rating on Outlook Therapeutics

23:41

Sep29

Outlook Therapeutics Completes Type A Meeting with FDA

13:37

Aug15

Outlook Therapeutics released FY2025 Q3 earnings on August 14 (EST), actual revenue USD 1.505 M (forecast USD 1.663 M), actual EPS USD -0.5499 (forecast USD -0.3525)

03:00

Outlook Therapeutics released FY2025 9 Months Earnings on August 14 EST, with actual revenue of USD 1.505 M and EPS of USD -1.3343

03:00